Skip to main content

Table 2 Main reported dimensions of improvements and concerns related to therapy

From: Challenges in implementing opioid agonist therapy in Lebanon: a qualitative study from a user’s perspective

  Users with good access to therapy (G1) (N = 52) Users with limited access to therapy (G2) (N = 29)
Reported improvements n (%) n (%)
Physical health 37 (71.2%) 8 (27.6%)
Mental health 39 (75.0%) 11 (37.9%)
Reducing drug cravings 41 (78.9%) 4 (13.8%)
Abstinence from other drugs 33 (63.5%) 2 (6.9%)
Social functioning 42 (80.8%) 12 (41.4%)
Family relations 34 (65.4%) 14 (48.3%)
Self-image and confidence 44 (84.6%) 11 (37.9%)
Avoiding arrest 47 (90.4%) 26 (89.7%)
Reducing financial burden 50 (96.2%) 20 (69.0%)
Reported concerns n (%) n (%)
Dependence to buprenorphine 29 (55.8%) 21 (72.4%)
Treatment side-effects 9 (17.3%) 19 (65.5%)
Geographical access 7 (13.5%) 4 (13.8%)
Time and other logistic constraints 11 (21.2%) 8 (27.6%)
Treatment cost 6 (11.5%) 27 (93.1%)
Difficulty to adhere to treatment protocol 13 (25.0%) 19 (65.5%)